Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) have been assigned an average rating of “Moderate Buy” from the five research firms that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $32.00.

Several research analysts have recently commented on GRDN shares. Truist Financial lifted their price target on shares of Guardian Pharmacy Services from $30.00 to $34.00 and gave the company a “buy” rating in a report on Friday, November 14th. Wall Street Zen raised shares of Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a report on Monday, November 17th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Guardian Pharmacy Services in a report on Monday, December 29th. Finally, Stephens increased their price target on Guardian Pharmacy Services from $35.00 to $36.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 14th.

Guardian Pharmacy Services Price Performance

Guardian Pharmacy Services stock opened at $34.77 on Thursday. Guardian Pharmacy Services has a 12 month low of $17.78 and a 12 month high of $37.43. The company has a fifty day moving average price of $31.55 and a two-hundred day moving average price of $29.06. The company has a market cap of $2.20 billion, a PE ratio of 55.19 and a beta of 0.86.

Institutional Trading of Guardian Pharmacy Services

A number of large investors have recently modified their holdings of the company. State of Alaska Department of Revenue acquired a new position in Guardian Pharmacy Services during the 3rd quarter valued at about $30,000. Parkside Financial Bank & Trust bought a new stake in shares of Guardian Pharmacy Services during the second quarter valued at approximately $41,000. Ameritas Investment Partners Inc. raised its holdings in shares of Guardian Pharmacy Services by 26.5% during the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock valued at $43,000 after buying an additional 345 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of Guardian Pharmacy Services during the second quarter worth approximately $43,000. Finally, Police & Firemen s Retirement System of New Jersey grew its holdings in Guardian Pharmacy Services by 76.8% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock worth $52,000 after buying an additional 1,062 shares in the last quarter.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.